» Authors » Alexandre Vargas Schwarzbold

Alexandre Vargas Schwarzbold

Explore the profile of Alexandre Vargas Schwarzbold including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 139
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Queiroga A, Barbosa D, Campos T, Schwarzbold A, Siqueira A, Salvato R, et al.
IJID Reg . 2025 Mar; 14:100577. PMID: 40026613
Introduction: Dengue fever is expanding worldwide on the track of climate change. In 2024, more than 14 million cases were reported. Around 6.5 million of those were reported in Brazil...
2.
de Andrade C, Luz F, de Oliveira N, Kopittke L, Rosa L, Dos Reis Gomes A, et al.
Front Med (Lausanne) . 2024 Aug; 11:1390057. PMID: 39118660
Context: COVID-19 induces complex distress across physical, psychological, and social realms and palliative care (PC) has the potential to mitigate this suffering significantly. Objectives: To describe the clinical characteristics and...
3.
Piccoli B, Y Castro T, Tessele L, Casarin B, Seerig A, Vieira A, et al.
Sci Rep . 2024 Jul; 14(1):16831. PMID: 39039137
The COVID-19 pandemic has been marked by novel viral variants, posing challenges to global public health. Recombination, a viral evolution mechanism, is implicated in SARS-CoV-2's ongoing evolution. The XBB recombinant...
4.
Delfino-Pereira P, Ventura V, Pires M, Ponce D, Assis Lopes do Carmo G, do Carmo L, et al.
Front Med (Lausanne) . 2024 Apr; 11:1350657. PMID: 38686364
Patients with chronic kidney disease (CKD), especially those on dialysis or who have received a kidney transplant (KT), are considered more vulnerable to severe COVID-19. This susceptibility is attributed to...
5.
Gomes V, Pires M, Pereira P, Schwarzbold A, Dos Reis Gomes A, Pessoa B, et al.
Respir Med . 2024 Apr; 227:107635. PMID: 38641122
Purpose: To develop a mortality risk score for COVID-19 patients admitted to intensive care units (ICU), and to compare it with other existing scores. Materials And Methods: This retrospective observational...
6.
Nogueira M, Nobre V, Pires M, Ramos L, Ribeiro Y, Aguiar R, et al.
Front Med (Lausanne) . 2024 Feb; 11:1363948. PMID: 38357642
[This corrects the article DOI: 10.3389/fmed.2023.1130218.].
7.
Fry S, Chokephaibulkit K, Pallem S, Henry O, Pu Y, Akawung A, et al.
Open Forum Infect Dis . 2023 Dec; 10(12):ofad553. PMID: 38088983
Background: Incidence data of respiratory syncytial virus-associated lower respiratory tract illness (RSV-LRTI) are sparse in low- and middle-income countries (LMICs). We estimated RSV-LRTI incidence rates (IRs) in infants in LMICs...
8.
Souza-Silva M, Pereira D, Pires M, Vasconcelos I, Schwarzbold A, Vasconcelos D, et al.
Arq Bras Cardiol . 2023 Oct; 120(9):e20220935. PMID: 37878893
Background: Despite no evidence showing benefits of hydroxychloroquine and chloroquine with or without azithromycin for COVID-19 treatment, these medications have been largely prescribed in Brazil. Objectives: To assess outcomes, including...
9.
Vieira A, Piccoli B, Y Castro T, Casarin B, Tessele L, Martins R, et al.
Sci Rep . 2023 Sep; 13(1):15189. PMID: 37709838
Antimicrobial-resistant Klebsiella pneumoniae is a global threat to healthcare and an important cause of nosocomial infections. Antimicrobial resistance causes prolonged treatment periods, high mortality rates, and economic impacts. Whole Genome...
10.
Sales T, Souza-Silva M, Delfino-Pereira P, Neves J, Sacioto M, de Assis V, et al.
Clinics (Sao Paulo) . 2023 Jun; 78:100223. PMID: 37331214
Objective: To evaluate clinical characteristics and outcomes of COVID-19 patients infected with HIV, and to compare with a paired sample without HIV infection. Methods: This is a substudy of a...